What If a Skin Cell Could Be Given a New Identity?
A skin cell seems like it should remain a skin cell.
It has already developed a specialized identity, performs a particular job, and carries molecular patterns that help maintain that identity.
But scientists discovered something remarkable:
Under carefully controlled laboratory conditions, mature cells can be pushed back into a much more flexible biological state.
These cells are known as induced pluripotent stem cells, or iPSCs.
The discovery transformed stem-cell biology and eventually raised another fascinating question:
If scientists can reset aspects of a cell's identity, what could cellular reprogramming teach us about aging?
A 2018 study took the idea one step further by using a CRISPR-based gene-activation system to reprogram primary human skin fibroblasts into iPSCs.
But what happened in that experiment is often much more interesting and much more specific than the phrase "scientists reversed aging."
First: What Is Cellular Reprogramming?
Most cells in your body are specialized.
A skin fibroblast behaves differently from a neuron. A muscle cell behaves differently from a liver cell.
Yet these cells generally contain essentially the same genome.
What differs is which genes are active and how the cell interprets that genetic information.
Cellular reprogramming attempts to change this biological program.
One of the most important breakthroughs came from research showing that mature cells could be converted into induced pluripotent stem cells by activating a small group of transcription factors.
The classic combination includes:
OCT4 + SOX2 + KLF4 + c-MYC
These are commonly called the Yamanaka factors.
Instead of remaining committed to their original identity, successfully reprogrammed cells enter a state resembling pluripotent stem cells.
That's a major biological reset.
What Does "Pluripotent" Actually Mean?
Pluripotency doesn't simply mean a cell is "younger."
It describes what the cell is capable of becoming.
A pluripotent stem cell can potentially differentiate into cell types representing all three major embryonic germ layers, giving it the capacity to generate many different specialized cell types.
So when scientists convert a skin fibroblast into an iPSC, they aren't simply making a slightly younger skin cell.
They're dramatically changing its cellular identity.
The fibroblast loses much of its specialized state and becomes an embryonic-like pluripotent cell.
That's why full cellular reprogramming and "reversing aging" are not interchangeable ideas.
What Did the 2018 CRISPRa Study Do?
This is where the experiment becomes particularly interesting.
Traditional reprogramming methods can introduce external copies of reprogramming-factor genes into cells.
Researchers wanted to know whether they could instead activate the genes already present inside the cell's own genome.
They used a technology called CRISPR activation or CRISPRa.
Unlike conventional CRISPR gene editing, which is often discussed in terms of cutting DNA, CRISPRa can be designed to switch specific genes on without making the same kind of DNA cut.
in primary human skin fibroblasts.
The result?
The researchers successfully generated induced pluripotent stem cells using CRISPRa.
Read the 2018 CRISPRa study on PubMed
Why Was That Important?
The experiment demonstrated something fundamental.
Scientists didn't necessarily need to rely on externally introduced copies of the classic reprogramming genes to push these human cells toward pluripotency.
Instead, they could use CRISPRa to activate the cells' own endogenous pluripotency network.
The researchers also found that targeting an additional conserved DNA sequence enriched near genes involved in early embryonic genome activation substantially improved the otherwise low reprogramming efficiency. This was associated partly with more effective activation of genes including NANOG and REX1.
In simple terms:
It's a striking demonstration of how much cellular identity depends on gene regulation.
So Did Scientists Make Old Skin Young Again?
Not in the way that statement would normally be understood.
This experiment showed that cultured human skin fibroblasts could be reprogrammed into iPSCs.
It did not show that researchers:
- Rejuvenated a person's skin
- Reversed wrinkles
- Reversed whole-body biological aging
- Extended human lifespan
- Made an older person biologically young
- Demonstrated a safe anti-aging treatment
The cells underwent full reprogramming toward pluripotency.
That's very different from safely rejuvenating an existing skin cell while allowing it to remain a functioning skin cell.
And that distinction leads directly to one of today's most interesting areas of longevity research.
Why Does Cellular Reprogramming Interest Aging Researchers?
Full reprogramming doesn't just change cell identity.
Research has shown that the process can also reset several molecular characteristics associated with cellular age.
This creates a fascinating biological observation:
Some features associated with cellular aging appear to be reversible when a cell is completely reprogrammed.
Researchers have therefore used iPSCs as tools for studying the relationship between cell identity, epigenetic state and cellular age.
But there's a major problem.
If you completely reprogram a mature cell into a pluripotent stem cell, you've also erased much of what made it that specialized cell in the first place.
For potential rejuvenation therapies, researchers would ideally like to separate:
the resetting of age-associated cellular features
from
the loss of cellular identity.
And that's where partial reprogramming enters the picture.
Full Reprogramming vs. Partial Reprogramming
Imagine an aging skin cell.
Full reprogramming asks:
Can we take this cell all the way back to pluripotency?
Partial reprogramming asks something different:
Can we temporarily activate reprogramming mechanisms enough to reset certain age-associated features without making the cell forget that it's a skin cell?
That second question has become particularly important in longevity research.
Recent reviews describe experimental evidence that transient reprogramming can affect molecular hallmarks associated with aging while attempting to preserve cell identity. But much of this work remains preclinical, and major questions remain around delivery, genomic stability, tumor risk, loss of cell identity, and precise control over how long reprogramming factors are active.
In other words:
Full reprogramming:
Mature cell → pluripotent state
Partial reprogramming:
Mature cell → temporary reprogramming signals → attempt to preserve original identity
The second approach is one reason cellular reprogramming has become such an important topic in longevity science.
Why Can't Scientists Simply Reprogram Our Cells?
Because changing cellular identity is powerful and powerful biological interventions can carry serious risks.
Full pluripotency isn't something researchers want occurring uncontrollably inside tissues.
Potential concerns in reprogramming research include:
Loss of cell identity
A specialized cell may stop performing the function the tissue needs.
Uncontrolled growth and tumor formation
Pluripotent cells have powerful proliferative and developmental capabilities, making precise control essential.
Incomplete reprogramming
Cells may enter abnormal intermediate states instead of reaching the intended biological state.
Delivery
Researchers need methods capable of affecting the correct cells, in the correct tissue, for the correct amount of time.
Recent research therefore focuses heavily on controlling where, when, and for how long reprogramming programs are activated.
What Does This Research Actually Tell Us About Aging?
Perhaps the most interesting lesson isn't that scientists have discovered a way to make humans young again.
They haven't.
The deeper finding is that cellular age may not be entirely fixed.
Experiments with iPSCs demonstrate that mature cellular programs can be extensively rewritten and that some molecular characteristics associated with cellular age can change during that process.
That has changed the questions researchers can ask.
Instead of only asking:
"Why do cells age?"
Scientists can also ask:
"Which age-associated changes can be reset?"
"Which changes should not be reset?"
"Can rejuvenation be separated from loss of cellular identity?"
"Can this ever be done safely inside a living human?"
Those questions are much closer to the frontier of the science.
What Has and Hasn't Been Proven?
Researchers have shown:
Human skin fibroblasts can be reprogrammed into induced pluripotent stem cells.
Defined transcription factors can dramatically alter cellular identity.
CRISPRa can activate endogenous pluripotency genes and was used to generate human iPSCs in the 2018 study.
Reprogramming can reset some molecular and epigenetic features associated with cellular age, which is one reason the process is being investigated in aging research.
Researchers have not established:
That cellular reprogramming can safely reverse whole-body aging in humans.
That the 2018 CRISPRa experiment was an anti-aging treatment.
That turning skin cells into iPSCs rejuvenates human skin in a living person.
That partial reprogramming is currently a proven general therapy for human aging.
Those differences are crucial.
The Bigger Question: Can Cellular Age Be Rewritten?
Twenty years of iPSC research have transformed cellular biology, and the technology is now used across areas including disease modeling, drug discovery, regenerative medicine and rejuvenation research.
But the field is moving from one remarkable question to an even harder one.
Scientists already know they can dramatically reset cellular identity under laboratory conditions.
Now they're asking whether parts of that biological reset can eventually be controlled precisely enough to influence age-associated cellular changes without erasing the cell's identity or creating unacceptable risks.
That's a much bigger challenge.
And it remains an active area of research.
Want to Explore More Longevity Research?
Cellular reprogramming is just one of the areas changing how scientists think about aging.
From cellular senescence and epigenetic changes to NAD+ metabolism, mitochondrial biology and partial reprogramming, researchers are investigating aging at increasingly detailed levels.
Explore more Aeternum longevity research →
Follow Aeternum for clear breakdowns of emerging longevity studies including what researchers actually found, what the headlines leave out, and what hasn't been proven yet.
Research Featured in This Article
Weltner J, et al. (2018). Human pluripotent reprogramming with CRISPR activators.
PMID: 29980666.
View the study on PubMed
Mertens J, et al. (2015). Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency.
PMID: 26046759.
View on PubMed
Li RL, Zou YZ, Kang S. (2025). Decoding Aging through iPSC Reprogramming: Advances and Challenges.
PMID: 40354373.
View on PubMed